Objective
To determine whether rapid polymerase chain reaction (
PCR
) testing for influenza and respiratory syncytial viruses (
RSV
) in emergency departments (
ED
s) is associated with better patient and laboratory outcomes than standard multiplex
PCR
testing.
Design, setting
A before‐and‐after study in four metropolitan
ED
s in New South Wales.
Participants
1491 consecutive patients tested by standard multiplex
PCR
during July–December 2016, and 2250 tested by rapid
PCR
during July–December 2017.
Main outcome measures
Hospital admissions;
ED
length of stay (
LOS
); test turnaround time; patient receiving test result before leaving the
ED
; ordering of other laboratory tests.
Results
Compared with those tested by standard
PCR
, fewer patients tested by rapid
PCR
were admitted to hospital (73.3%
v
77.7%;
P
< 0.001) and more received their test results before leaving the
ED
(67.4%
v
1.3%;
P
< 0.001); the median test turnaround time was also shorter (2.4 h [
IQR
, 1.6–3.9 h]
v
26.7 h [
IQR
, 21.2–37.8 h]). The proportion of patients admitted to hospital was also lower in the rapid
PCR
group for both children under 18 (50.6%
v
66.6%;
P
< 0.001) and patients over 60 years of age (84.3%
v
91.8%;
P
< 0.001). Significantly fewer blood culture, blood gas, sputum culture, and respiratory bacterial and viral serology tests were ordered for patients tested by rapid
PCR
.
ED LOS
was similar for the rapid (7.4 h;
IQR
, 5.0–12.9 h) and standard
PCR
groups (6.5 h;
IQR
, 4.2–11.9 h;
P
= 0.27).
Conclusion
Rapid
PCR
testing of
ED
patients for influenza virus and
RSV
was associated with better outcomes on a range of indicators, suggesting benefits for patients and the health care system. A formal cost–benefit analysis should be undertaken.